Top

Clinical & Experimental Metastasis

Published in:

01-11-2003

Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells

Authors: Tomoko Okada, Shingo Akikusa, Hiroaki Okuno, Masato Kodaka

Published in: Clinical & Experimental Metastasis | Issue 7/2003

Title: Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells
Authors: Tomoko Okada
Shingo Akikusa
Hiroaki Okuno
Masato Kodaka
Publication date: 01-11-2003
Publisher: Kluwer Academic Publishers
Published in: Clinical & Experimental Metastasis / Issue 7/2003
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI: https://doi.org/10.1023/A:1027362507683

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 7/2003

Expression of the 67 kDa laminin receptor and the α6 integrin subunit in serous ovarian carcinoma

The meaning of the c-kit proto-oncogene product in malignant transformation in human mammary epithelium

Increased metastatic potential in human prostate carcinoma cells by overexpression of arachidonate 12-lipoxygenase

Inhibitory effect of antisense aminopeptidase N (APN/CD13) cDNA transfection on the invasive potential of osteosarcoma cells

Real-time imaging of individual fluorescent-protein color-coded metastatic colonies in vivo

Suppression of pancreatic cancer cell invasion by a cyclooxygenase-2-specific inhibitor

Keynote webinar | Spotlight on antibody–drug conjugates in cancer